Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by XTX Topco Ltd

XTX Topco Ltd reduced its position in Teladoc Health, Inc. (NYSE:TDOC) by 15.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,046 shares of the health services provider’s stock after selling 3,926 shares during the quarter. XTX Topco Ltd’s holdings in Teladoc Health were worth $206,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of TDOC. ICA Group Wealth Management LLC acquired a new position in shares of Teladoc Health in the fourth quarter valued at approximately $28,000. Signaturefd LLC increased its position in shares of Teladoc Health by 148.7% during the second quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock worth $28,000 after acquiring an additional 1,715 shares during the period. International Assets Investment Management LLC acquired a new stake in shares of Teladoc Health in the second quarter valued at $29,000. SageView Advisory Group LLC purchased a new position in Teladoc Health in the first quarter valued at $48,000. Finally, Covestor Ltd grew its stake in Teladoc Health by 58.1% during the 1st quarter. Covestor Ltd now owns 3,817 shares of the health services provider’s stock worth $57,000 after purchasing an additional 1,403 shares in the last quarter. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Price Performance

TDOC stock opened at $8.46 on Monday. The company has a current ratio of 1.66, a quick ratio of 1.62 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $1.43 billion, a P/E ratio of -6.00 and a beta of 0.90. The business has a 50 day simple moving average of $7.93 and a 200-day simple moving average of $10.62. Teladoc Health, Inc. has a twelve month low of $6.76 and a twelve month high of $22.54.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.36) by $0.08. The company had revenue of $642.44 million for the quarter, compared to the consensus estimate of $649.34 million. Teladoc Health had a negative net margin of 38.54% and a negative return on equity of 10.25%. As a group, equities analysts anticipate that Teladoc Health, Inc. will post -1.18 EPS for the current year.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Oppenheimer decreased their price objective on Teladoc Health from $21.00 to $17.00 and set an “outperform” rating for the company in a research note on Thursday, August 1st. Barclays lowered their price target on shares of Teladoc Health from $20.00 to $10.00 and set an “overweight” rating for the company in a report on Thursday, August 1st. Jefferies Financial Group raised their price objective on shares of Teladoc Health from $8.00 to $10.00 and gave the company a “hold” rating in a report on Tuesday, September 17th. Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a research report on Thursday, August 1st. Finally, TD Cowen dropped their target price on Teladoc Health from $15.00 to $9.00 and set a “hold” rating on the stock in a report on Thursday, August 1st. Fifteen research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, Teladoc Health has a consensus rating of “Hold” and an average target price of $12.31.

Insider Buying and Selling

In related news, Director Thomas Mckinley acquired 4,000 shares of Teladoc Health stock in a transaction on Thursday, September 12th. The stock was purchased at an average cost of $7.69 per share, with a total value of $30,760.00. Following the purchase, the director now directly owns 39,077 shares in the company, valued at $300,502.13. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Teladoc Health news, insider Vidya Raman-Tangella sold 3,857 shares of the business’s stock in a transaction on Friday, August 2nd. The shares were sold at an average price of $8.14, for a total value of $31,395.98. Following the transaction, the insider now directly owns 33,667 shares of the company’s stock, valued at approximately $274,049.38. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Thomas Mckinley bought 4,000 shares of Teladoc Health stock in a transaction dated Thursday, September 12th. The stock was purchased at an average price of $7.69 per share, with a total value of $30,760.00. Following the purchase, the director now directly owns 39,077 shares in the company, valued at approximately $300,502.13. The disclosure for this purchase can be found here. Insiders have sold a total of 57,819 shares of company stock valued at $442,204 over the last quarter. 0.95% of the stock is currently owned by insiders.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.